David Jaro Vocadlo

USPTO Granted Patents = 21 (Patent Applications = 11)

CIPO Patents = 5 (Patent Applications = 7)

EPO Patents = 13 (Patent Applications = 12)

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 89(Granted Patents)

Company Filing History:

14 out of 18

Alectos Therapeutics Inc.

patents

12 out of 2,405

Merck Sharp + Dohme Corp.

patents

5 out of 155

Simon Fraser University

patents

4. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11396522 - Bis-acetal-based substrates for imaging exo-glycosidase activity (2022-07-26),

2. 10081601 - Glucocerebrosidase modulators and uses thereof (2018-09-25),

3. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),

4. 9809537 - Glycosidase inhibitors and uses thereof (2017-11-07),

5. 9796680 - Glucocerebrosidase modulators and uses thereof (2017-10-24),

6. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),

7. 9701693 - Selective glycosidase inhibitors and uses thereof (2017-07-11),

8. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),

9. 9670195 - Glycosidase inhibitors and uses thereof (2017-06-06),

10. 9522883 - Glycosidase inhibitors and uses thereof (2016-12-20),

11. 9409924 - Selective glycosidase inhibitors and uses thereof (2016-08-09),

12. 9243020 - Selective glycosidase inhibitors and uses thereof (2016-01-26),

13. 9199949 - Selective glycosidase inhibitors and uses thereof (2015-12-01),

14. 9120781 - Selective glycosidase inhibitors and uses thereof (2015-09-01),

15. 9079868 - Selective glycosidase inhibitors and uses thereof (2015-07-14),

Title: David Jaro Vocadlo - Innovator in Glycosidase Research

Introduction

David Jaro Vocadlo is a prominent inventor based in Burnaby, Canada, known for his significant contributions to biochemistry and glycosidase research. With a remarkable portfolio of 21 patents, Vocadlo has made strides in developing innovative technologies that enhance our understanding of enzyme activity.

Latest Patents

Two of Vocadlo's latest patents exemplify his groundbreaking work. The first, titled "Bis-acetal-based substrates for imaging exo-glycosidase activity," presents fluorescence-quenched substrates designed for exo-glycosidase enzymes. This invention offers methods for imaging the activity of these enzymes within living cells, providing valuable insights into cellular processes. The second patent, "Glucocerebrosidase modulators and uses thereof," details compounds that can modulate glycosidases, along with prodrugs and pharmaceutical compositions incorporating these compounds. These innovations highlight Vocadlo's dedication to advancing therapeutic options and understanding enzyme functionality.

Career Highlights

David Jaro Vocadlo has built an impressive career working with various esteemed organizations, including Alectos Therapeutics Inc. and Merck Sharp & Dohme Corporation. His experience in these companies has allowed him to engage in collaborative and cutting-edge research, leading to his numerous patents and contributions to the field.

Collaborations

Throughout his career, Vocadlo has collaborated with notable individuals such as Ernest John McEachern and Yuanxi Zhou. These partnerships have been crucial in fostering an environment of innovation and exploration within enzyme research, facilitating the development of new technologies and methodologies.

Conclusion

David Jaro Vocadlo stands as a key figure in the realm of biochemistry, particularly in glycosidase research. His 21 patents underscore his innovative spirit and commitment to advancing our understanding of enzymes and their applications. As he continues to collaborate with others in the field, his work will undoubtedly influence future research and technological advancements.

This text is generated by artificial intelligence and may not be accurate.